Success Metrics

Clinical Success Rate
83.3%

Based on 5 completed trials

Completion Rate
83%(5/6)
Active Trials
0(0%)
Results Posted
20%(1 trials)
Terminated
1(17%)

Phase Distribution

Ph phase_2
1
17%
Ph phase_1
5
83%

Phase Distribution

5

Early Stage

1

Mid Stage

0

Late Stage

Phase Distribution6 total trials
Phase 1Safety & dosage
5(83.3%)
Phase 2Efficacy & side effects
1(16.7%)

Highest Phase Reached

Phase 2

Trial Status & Enrollment

Completion Rate

83.3%

5 of 6 finished

Non-Completion Rate

16.7%

1 ended early

Currently Active

0

trials recruiting

Total Trials

6

all time

Status Distribution
Completed(5)
Terminated(1)

Detailed Status

Completed5
Terminated1

Development Timeline

Analytics

Development Status

Total Trials
6
Active
0
Success Rate
83.3%
Most Advanced
Phase 2

Trials by Phase

Phase 15 (83.3%)
Phase 21 (16.7%)

Trials by Status

completed583%
terminated117%

Recent Activity

0 active trials
Showing 5 of 6
terminatedphase_2

A Long Term Safety Study Of Lersivirine For The Treatment Of HIV-1 Infection In Subjects Who Have Completed Treatment With Lersivirine In Studies A5271015 And A5271022

NCT01254656
completedphase_1

Safety And Tolerability Of Multiple Dose Lersivirine For 21 Days In Healthy Subjects

NCT01230385
completedphase_1

Estimate The Effect Of Lersivirine On The Pharmacokinetics Of Abacavir/Lamivudine In Healthy Subjects

NCT01220232
completedphase_1

Drug Interaction Study Between Rifabutin And Lersivirine (UK-453,061)

NCT00925535
completedphase_1

The Effect Of Lersivirine (UK-453,061) On Qt Intervals In Healthy Subjects

NCT00936871
View all 6 trials

Clinical Trials (6)

Showing 6 of 6 trials
NCT01254656Phase 2

A Long Term Safety Study Of Lersivirine For The Treatment Of HIV-1 Infection In Subjects Who Have Completed Treatment With Lersivirine In Studies A5271015 And A5271022

Terminated
NCT01230385Phase 1

Safety And Tolerability Of Multiple Dose Lersivirine For 21 Days In Healthy Subjects

Completed
NCT01220232Phase 1

Estimate The Effect Of Lersivirine On The Pharmacokinetics Of Abacavir/Lamivudine In Healthy Subjects

Completed
NCT00925535Phase 1

Drug Interaction Study Between Rifabutin And Lersivirine (UK-453,061)

Completed
NCT00936871Phase 1

The Effect Of Lersivirine (UK-453,061) On Qt Intervals In Healthy Subjects

Completed
NCT01050751Phase 1

Bioavailability Of Lersivirine Single 750 Mg Tablet Versus 3 X 250 Mg Tablets

Completed

All 6 trials loaded

Drug Details

Intervention Type
DRUG
Total Trials
6